Fred Hutch researchers have created a gene-expression map of glial cells of the tiny worm, C. elegans, adding the missing ...

During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that causes AIDS. He co-founded the field of paleovirology and considers ...

A new AI application that is part of an 'ambient listening' pilot program is helping physicians at Fred Hutch Cancer Center ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

Proton therapy is an advanced radiation treatment that precisely targets tumors with a goal of limiting harm to healthy tissue. It may help reduce short- and long-term side effects, lower the risk of ...

Tammy Miller has been a wealth and philanthropy advisor for over 30 years. As executive director of the Aldarra Foundation, ...

Faculty profile for Dr. Christopher D. Blosser. Dr. Blosser is a transplant nephrologist and medical director of the Cancer ...

Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes ...

The fifth Symposium on Infectious Disease in the Immunocompromised Host convened in Seattle last month. Experts and rising stars in the field met to share practice-changing research, discuss tricky ...

Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.

Fred Hutch Cancer Center aims to enroll 200,000 patients over the next 10 years in a new research program called TakePART-NW (Patients and Research Together-Northwest) to improve screening, prevention ...

Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees, nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential.